Just like efforts and resources have been put in place to address breast, cervical and prostate cancers by both public and private stakeholders in healthcare, similar investment for
colorectal cancer and emphasis on regular screening is vital for early diagnosis at manageable and treatable stages especially because
colorectal cancer may not show any symptoms during the early stages.
Patients with hereditary
colorectal cancer syndromes
"In two health systems with high rates of screening, we observed that most patients dying from
colorectal cancer had potentially modifiable failures of the screening process," the researchers noted.
Compared with women with the lowest BMIs (18.5-22.9 kilograms per square meter), women with the highest BMI (greater than 30) had almost twice the risk of early-onset
colorectal cancer. According to the Centers for Disease Control and Prevention, the normal BMI range is 18.5-24.9 kilograms per square meter.
Colorectal cancers are detected via a colonoscopy and if large polyps are discovered, a biopsy follows.
* Nearly 140,000 people were diagnosed with
colorectal cancer, including:
Single flexible sigmoidoscopy screening to prevent
colorectal cancer: baseline findings of a UK multicentre randomised trial.
28 in the Journal of the National Cancer Institute found that the national rate of
colorectal cancers has decreased by around 3 percent annually.
Results: In 210 specimens of
colorectal cancer, the positive expression rate of CD133, E-cadherin and WWOX was 61.9%, 40.5% and 41.9%, respectively.
1 in 21 (4.7%) is the lifetime risk of developing
colorectal cancer for men.
Colorectal cancer survival is highly dependent on the stage of disease at diagnosis, and typically ranges from a 90% 5-year survival rate for cancers detected at the localized stage, through 70% for the regional stage, to 10% for people diagnosed for distant metastatic cancer.